Accession Number: | 0000899243-21-026528 |
Date: | 2021-06-25 |
Issuer: | T2 BIOSYSTEMS, INC. (TTOO) |
Original Submission Date: |
ELSBREE DAVID B
101 HARTWELL AVENUE
LEXINGTON, MA 02421
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-06-25 | M | 45,454 | a | $0.00 | 170,723 | direct | ||
COMMON STOCK | 2021-06-25 | 0 | $0.00 | 10,000 | indirect | f2 |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
RESTRICTED STOCK UNITS | 0.0 | 2021-06-25 | deemed execution date | M | 45,454 (d) | common stock 45,454 | $0.00 | 45,454 | direct | |||
RESTRICTED STOCK UNITS | 0.0 | 2021-06-25 | deemed execution date | A | 73,224 (a) | common stock 73,224 | $0.00 | 73,224 | direct |
ID | footnote |
---|---|
f1 | each restricted stock unit represents a contingent right to receive one share of issuer's common stock. |
f2 | the reporting person disclaims ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of section 16 or for any other purpose. |
f3 | on august 6, 2020 the reporting person was granted 45,454 restricted stock units that vested on june 25, 2021. |
f4 | the restricted stock units vest in one installment on the earlier of (i) june 25, 2022 and (ii) the date of the next annual meeting of stockholders. |